Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Addressing Emotional and Cognitive Factors in Behavioral Weight Loss Treatment

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2011 by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
ClinicalTrials.gov Identifier:
NCT00533052
First received: September 20, 2007
Last updated: January 31, 2011
Last verified: January 2011
  Purpose

Behavioral weight loss, the current treatment of choice for moderate obesity, achieves impressive short term results, however, weight regain following treatment is a major problem. Over 50% of participants in behavioral weight loss programs report difficulty with internal antecedents to unhealthy weight control behaviors and this difficulty is associated with weight regain following treatment. Current treatment approaches do not adequately address these antecedents. The aim of this series of studies is to develop, implement, and evaluate a behavioral weight loss program modified to provide participants with skills to deal effectively with affective and cognitive difficulties. The study targets men and women with BMI of 27-40 who self-report difficulty with emotional and/or cognitive antecedents to unhealthy weight control behaviors. The study is an uncontrolled pilot study in 20 participants to initially assess acceptability and efficacy of the innovative treatment. The long-term goal of this research is to improve the weight loss maintenance outcomes of behavioral weight loss programs by addressing affective and cognitive antecedents to unhealthy weight control behaviors.


Condition Intervention
Overweight
Obesity
Behavioral: Standard Behavioral Weight Loss Treatment Plus Affective and Cognitive Skills Training

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Addressing Emotional and Cognitive Factors in Behavioral Weight Loss Treatment

Resource links provided by NLM:


Further study details as provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK):

Primary Outcome Measures:
  • Body Mass Index [ Time Frame: 6 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Internal disinhibition as measured by the Eating Inventory [ Time Frame: 6 months ] [ Designated as safety issue: No ]
  • Treatment acceptability based on qualitative feedback [ Time Frame: 6 months ] [ Designated as safety issue: No ]
  • Attendance data [ Time Frame: 6 months ] [ Designated as safety issue: No ]

Enrollment: 21
Study Start Date: October 2007
Estimated Study Completion Date: May 2008
Arms Assigned Interventions
Experimental: 1
Standard Behavioral Weight Loss Treatment Plus Affective and Cognitive Skills Training
Behavioral: Standard Behavioral Weight Loss Treatment Plus Affective and Cognitive Skills Training
24-week, weekly, group behavioral weight loss treatment with affective and cognitive skills training

  Eligibility

Ages Eligible for Study:   21 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Age between 21 and 70 years
  • Body mass index between 27 and 40
  • Score 5 or above on the internal disinhibition scale of the Eating Inventory

Exclusion Criteria:

  • Are currently participating in a weight loss program and/or are taking a weight loss medication or lost greater than or equal to 5% of body weight during the past six months
  • Are pregnant, lactating, less than 6 months postpartum or plan to become pregnant during the time frame of the investigation
  • Report a heart condition, chest pain during periods of activity or rest, or loss of consciousness on the Physical Activity Readiness Questionnaire (PAR-Q). Individuals endorsing joint problems, prescription medication usage, or other medical conditions that could limit exercise will be required to obtain written physician consent to participate.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00533052

Locations
United States, Rhode Island
The Miriam Hospital
Providence, Rhode Island, United States, 02903
Sponsors and Collaborators
Investigators
Principal Investigator: Heather M. Niemeier, Ph.D. The Miriam Hospital/The Warren Alpert Medical School of Brown University
  More Information

No publications provided

Responsible Party: Heather M. Niemeier, Ph.D., The Miriam Hospital
ClinicalTrials.gov Identifier: NCT00533052     History of Changes
Other Study ID Numbers: K23 DK73536 (completed), 1 K23 DK073536-01
Study First Received: September 20, 2007
Last Updated: January 31, 2011
Health Authority: United States: Federal Government

Keywords provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK):
Behavioral weight loss

Additional relevant MeSH terms:
Overweight
Weight Loss
Body Weight
Body Weight Changes
Signs and Symptoms

ClinicalTrials.gov processed this record on November 27, 2014